1Nanosonics Ltd, Head of Clinical Affairs
With the expanding use of complex, heat sensitive medical devices, semi-critical device reprocessing continues to be a challenge. In particular, ultrasound is among the fasting growing imaging modalities and is broadly used across a wide range of clinical settings, procedures and by a variety of end users. Ultrasound guidance is increasingly being used for invasive procedures including vascular access and biopsies as well as for more traditional semi-critical procedures such as transvaginal, transrectal and transoesopheal ultrasound. This complexity creates inevitable challenges but these can be addressed by improved education and awareness, improved reprocessing practices and through the use of technology.
This session will deliver the findings of a number of recent surveys by ICPs and sonographers on ultrasound probe reprocessing, highlighting issues in current practice, the complexity of applying guidelines and standards and practical solutions to improve processes. Key studies addressing issues such as disinfection of ultrasound probe handles, the resistance of human papillomavirus to disinfectants and manual versus automated processes will also be addressed.
Dr Burdach is currently Head of Clinical Affairs at Nanosonics Ltd, an ASX 200 company specialising in medical device reprocessing and infection control. He has a PhD in Biochemistry and Molecular Biology from the University of New South Wales and has worked in academic and commercial research settings and in medical and environmental microbiology laboratories. Dr Burdach is the author of over 15 publications in leading scientific journals.